Navigation Links
What patients want: A story of choice, clinical trials & evidence-based medicine

Clinical trials are serious business. In addition to being big business (untold billions of dollars every year), they also involve serious ethical issues and choices. We are all aware of the fundamental ethical principle of informed consent underlying all clinical trials.

What is less obvious is that co......

Full article >>> A Randomized Trial summarized this important clinical trial. They were also accompanied by two editorials and the trial results were significant enough to raise the attention of the national media, including an article in the New York Times - Study Ques......

Full article >>> the extremely high numbers of crossovers (45 to 60 percent of patients) and, to a lesser extent, a certain degree of missing data, such analyses are significantly confounded and should not be used to compare different strategies, as Dr. David Flum, a contributing editor at JAMA, wrote in his accompanying editorial.

Instea......

Full article >>> e? Where their pain thresholds higher yet their risk tolerance less? While the study yielded indefinite results, this much is for sure: patients want (and certainly act upon) choice.

It was a bit disappointing then to read further in the JAMA editorials that designing clinical trials with sham-controlled surgeries (e.g. operations in which the patient is cut but the actual restorative pr......

Full article >>> s="AuthorBio">Dr. Ogan Gurel is chairman of the Aesis Research Group, which provides forward-looking information and research services to the healthcare and life sciences investment community. Gurel was previously CEO of Duravest, a publicly traded Chicago investment company that initiates and develops next-generation medical technologies. Previous to Duravest, he was a vice president and medical ......

Full article >>>
'"/>

Source:wistechnology.com By Ogan Gurel 03/19/07


Related biology technology :

1. Sensitive detection of tumor cells in peripheral blood of carcinoma patients by a reverse transcription PCR method
2. Heart patients benefit from digital image network
3. RNA Interference and Gene Silencing: History and Overview
4. Google to place Wisconsin history online
5. The world of in-vitro diagnostics is another Midwest success story
6. The world of in vitro diagnostics is another Midwest success story
7. The end of technology history
8. Carl Christensen says Marshfield Clinics history gives it an IT edge
9. An entrepreneurial success story Frank Langley champions biocapitalism
10. When its parts pull together, Wisconsin can tell a compelling economic story
11. Berbees success is based on companys history and culture
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... USA, and CARDIFF, UK (PRWEB) , ... February ... ... international society for optics and photonics , have been named Fellows of the ... significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, and ...
(Date:2/22/2017)... ... February 22, 2017 , ... Park Systems , a ... Luncheon for all SPIE attendees and Park customers on Feb. 27, ... from the San Jose Convention Center. The luncheon will feature a talk on ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... leading medical education provider of women’s health, primary care, and specialty education, ... for Continuing Medical Education (ACCME). ACCME’s Accreditation with Commendation is a six-year ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... LabRoots ... and scientists from around the world, is pleased to announce the launch of a ... engineering and mathematics (STEM) fields. , This merit-based scholarship is open to all high ...
Breaking Biology Technology:
(Date:2/8/2017)... , Feb. 7, 2017 The biometrics ... by the confluence of organizations, desires to better ... knowledge-based systems (password and challenge questions), biometrics is ... government systems. The market is driven by use ... between consumer and enterprise uses cases, with consumer-facing ...
(Date:2/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... at the LEERINK Partners 6th Annual Global Healthcare Conference ... February 15, 2017 at 10 a.m. Eastern Time. ... be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast will ... Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:2/3/2017)...  Texas Biomedical Research Institute announced that its Board of ... as the Institute,s new President and CEO. Dr. Schlesinger will ... He is currently the Chair of the Department of Microbial ... Interface Biology at Ohio State University. "We are ... CEO of Texas Biomed," said Dr. James O. Rubin ...
Breaking Biology News(10 mins):